AIM ImmunoTech
13 hedge funds and large institutions have $2.49M invested in AIM ImmunoTech in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
131% more capital inflows, than outflows
Capital inflows: $38.4K | Capital outflows: $16.6K
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.28% less ownership
Funds ownership: 6.2% → 5.92% (-0.28%)
7% less funds holding
Funds holding: 14 → 13 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$38.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu KCG Holdings
New York
|
-$9.6K |
| 2 |
Wedbush Securities
Los Angeles,
California
|
-$7K |
AIM Hedge Fund Activity: Q3 2015 in Review
13 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2015, worth a combined $2.49M — down 16% from $2.95M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AIM and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $38.4K. The largest seller was Virtu KCG Holdings, cutting an estimated $9.6K.
- 13 institutional investors held AIM ImmunoTech (AIM) as of Q3 2015, down from 14 in Q2 2015.
- Funds reported $2.49M of AIM ImmunoTech stock for Q3 2015, down 16% quarter-over-quarter.
- 0 funds opened new AIM ImmunoTech positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest AIM ImmunoTech buyer in Q3 2015 was Renaissance Technologies, an estimated $38.4K added.
- The largest AIM ImmunoTech seller in Q3 2015 was Virtu KCG Holdings, an estimated $9.6K sold.
Based on aggregated 13F filings for Q3 2015.